CMOTEC B Share Price Performance
SEK 5.62
3.65 (185.28%)
Price SEK 5.62
Share PriceSEK 5.62
Scandinavian ChemoTech AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
CMOTEC B Community Narratives
There are no narratives available yet.
Recent CMOTEC B News & Updates
Scandinavian ChemoTech AB (publ) Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 04, 2025
- Earnings per share (EPS)
- -0.46
- Gross Margin
- 78.01%
- Net Profit Margin
- -108.34%
- Debt/Equity Ratio
- 0%
Scandinavian ChemoTech AB (publ) Competitors
Snowflake Analysis
About CMOTEC B
- Founded
- 2013
- Employees
- 2
- CEO
- WebsiteView website
Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden and Florida. The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distribution channels and a network of human medicine opinion leaders in the Middle East, Asia, India, and Africa. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Swedish Market Performance
- 7 Days: 0.8%
- 3 Months: 2.3%
- 1 Year: 0.5%
- Year to Date: 3.3%
Over the last 7 days, the market has risen 1.9%, driven by gains of 3.2% in the Industrials sector. As for last year, the market performance has been flat. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›